SCD-HeFT results published: more ICD (implantable cardioverter defibrillator) eligibility now in US?
This article was originally published in Clinica
Executive Summary
The number of Medicare beneficiaries eligible to receive an implantable cardioverter defibrillator (ICD) as a primary prevention against sudden cardiac death (SCD) could more than double, now that the results of Medtronic's SCD-HeFT trial have finally appeared in a peer-reviewed medical journal.